Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific CRP PTX1 ENSG00000132693 C-reactive protein, pentraxin-related 1 159712289-159714589 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005036, HPA027367, HPA027396 Supported Group enriched 68 gallbladder: 173.7;liver: 532.4 endometrium: 5.2 TM4SF4 il-TMP ENSG00000169903 Transmembrane 4 L six family member 4 3 149473974-149503281 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046430 Supported Approved Plasma membrane
Cytosol Group enriched 34 duodenum: 595.8;gallbladder: 1326.5;liver: 343.7;small intestine: 515.2 stomach: 20.3 FGF19 ENSG00000162344 Fibroblast growth factor 19 11 69698232-69704642 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036082 Approved Tissue enriched 27 gallbladder: 263.2 small intestine: 9.5 CHST4 HEC-GLCNAC-6-ST, LSST ENSG00000140835 Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 16 71525233-71538746 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021955 Supported Tissue enriched 13 gallbladder: 102.9 fallopian tube: 7.9 HABP2 FSAP, HABP, HGFAL, PHBP ENSG00000148702 Hyaluronan binding protein 2 10 113550837-113589602 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019518 Approved Group enriched 12 gallbladder: 56.0;liver: 225.6 stomach: 11.5 NR1I2 BXR, ONR1, PAR2, PXR, SXR ENSG00000144852 Nuclear receptor subfamily 1, group I, member 2 3 119780484-119818485 FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029309, HPA055121, HPA073926 Validated Nucleoplasm Group enriched 12 colon: 9.3;duodenum: 23.2;gallbladder: 6.0;liver: 19.7;rectum: 9.4;small intestine: 26.3 stomach: 1.3 F5 ENSG00000198734 Coagulation factor V (proaccelerin, labile factor) 1 169514166-169586588 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002036 Uncertain Approved Golgi apparatus Group enriched 11 gallbladder: 28.5;liver: 93.7;placenta: 67.7 fallopian tube: 5.8 MOGAT1 DGAT2L, DGAT2L1, MGAT1 ENSG00000124003 Monoacylglycerol O-acyltransferase 1 2 222671786-222709930 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049944 Uncertain Tissue enriched 11 gallbladder: 30.8 parathyroid gland: 2.8 MUC5B MG1, MUC5 ENSG00000117983 Mucin 5B, oligomeric mucus/gel-forming 11 1223066-1262172 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008246, CAB009396 Supported Validated Vesicles Group enriched 11 cervix, uterine: 347.7;gallbladder: 346.8 colon: 32.6 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 CYP2C18 CPCI, CYP2C, CYP2C17, P450IIC17 ENSG00000108242 Cytochrome P450, family 2, subfamily C, polypeptide 18 10 94683621-94736190 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 10 duodenum: 105.9;esophagus: 24.7;gallbladder: 24.5;liver: 97.7;small intestine: 90.0;stomach: 62.7 tonsil: 6.4 HHLA2 B7-H5, B7H7, B7y ENSG00000114455 HERV-H LTR-associating 2 3 108296490-108378285 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055478 Approved Group enriched 10 colon: 89.3;duodenum: 89.6;gallbladder: 46.3;rectum: 92.1;small intestine: 146.8 stomach: 9.3 CCKAR ENSG00000163394 Cholecystokinin A receptor 4 26481400-26490462 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 9 gallbladder: 47.3;stomach: 14.9 tonsil: 3.2 CHRDL2 BNF1 ENSG00000054938 Chordin-like 2 11 74696429-74731385 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021771 Uncertain Uncertain Mitochondria Group enriched 9 appendix: 162.3;endometrium: 128.0;gallbladder: 169.0;smooth muscle: 181.2;urinary bladder: 45.0 cervix: 14.5 CCL3L3 MGC12815 ENSG00000276085 Chemokine (C-C motif) ligand 3-like 3 17 36194869-36196758 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 bone marrow: 7.4;gallbladder: 1.5 lymph node: 0.5 CLRN3 MGC32871, TMEM12, USH3AL1 ENSG00000180745 Clarin 3 10 127877841-127892947 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014482 Approved Group enriched 8 colon: 71.2;duodenum: 75.4;gallbladder: 23.7;kidney: 43.9;liver: 40.2;rectum: 77.5;small intestine: 99.5 appendix: 7.5 DEFB4A DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 ENSG00000171711 Defensin, beta 4A 8 7894629-7896711 Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 esophagus: 6.0;gallbladder: 10.4;tonsil: 12.8 cervix: 1.1 HTR1D 5-HT1D, HT1DA, HTRL, RDC4 ENSG00000179546 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 1 23191895-23194729 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 duodenum: 9.7;gallbladder: 2.5;small intestine: 9.3 fallopian tube: 0.8 LRRC19 FLJ21302 ENSG00000184434 Leucine rich repeat containing 19 9 26993136-27005693 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Group enriched 8 colon: 36.8;duodenum: 24.4;gallbladder: 9.5;kidney: 45.4;rectum: 36.2;small intestine: 35.4 appendix: 3.7 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056430 Approved Vesicles
Microtubules Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 CAPN12 ENSG00000182472 Calpain 12 19 38730187-38769904 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043492, HPA053322 Uncertain Approved Nucleoplasm
Focal adhesion sites Tissue enriched 7 gallbladder: 35.0 cervix: 4.7 CES1 CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1 ENSG00000198848 Carboxylesterase 1 16 55802851-55833337 Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012023, HPA046717 Supported Validated Endoplasmic reticulum Group enriched 7 gallbladder: 400.5;liver: 1099.6;lung: 229.6 adipose tissue: 79.7 PPP1R14D CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016 ENSG00000166143 Protein phosphatase 1, regulatory (inhibitor) subunit 14D 15 40815445-40828709 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041846 Uncertain Group enriched 7 colon: 107.5;duodenum: 114.3;gallbladder: 24.3;rectum: 101.6;small intestine: 91.7 appendix: 12.9 UGT1A5 UGT1E ENSG00000240224 UDP glucuronosyltransferase 1 family, polypeptide A5 2 233712992-233773299 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 7 duodenum: 7.7;gallbladder: 3.9;small intestine: 6.9 liver: 0.9 ACE2 ENSG00000130234 Angiotensin I converting enzyme 2 X 15561033-15602148 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000288, CAB026174 Supported Group enriched 6 duodenum: 186.1;gallbladder: 100.6;kidney: 93.3;small intestine: 266.6;testis: 92.6 heart muscle: 23.1 C2CD4C FAM148C, KIAA1957, NLF3 ENSG00000183186 C2 calcium-dependent domain containing 4C 19 405438-409170 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055915 Uncertain Approved Vesicles Group enriched 6 adipose tissue: 2.5;cerebral cortex: 10.7;gallbladder: 4.4 endometrium: 0.9 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supported Group enriched 6 bone marrow: 110.9;colon: 184.1;esophagus: 174.2;gallbladder: 190.2;lung: 406.1;rectum: 236.9 appendix: 38.9 DUOX2 LNOX2, P138(TOX), P138-TOX, THOX2 ENSG00000140279 Dual oxidase 2 15 45092650-45114344 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 gallbladder: 448.6;thyroid gland: 124.3;urinary bladder: 90.1 stomach: 38.5 EPS8L3 FLJ21522, MGC16817 ENSG00000198758 EPS8-like 3 1 109750080-109764027 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030998 Approved Approved Vesicles Group enriched 6 colon: 76.3;duodenum: 156.3;gallbladder: 60.0;rectum: 87.4;small intestine: 170.4;stomach: 54.0 appendix: 15.8 ERN2 IRE1b ENSG00000134398 Endoplasmic reticulum to nucleus signaling 2 16 23690309-23713500 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016558 Uncertain Group enriched 6 cervix, uterine: 26.7;colon: 27.8;duodenum: 12.7;gallbladder: 25.2;rectum: 23.4;small intestine: 10.1;stomach: 49.9 appendix: 3.9 FXYD2 ATP1G1, HOMG2, MGC12372 ENSG00000137731 FXYD domain containing ion transport regulator 2 11 117800844-117828698 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064218, HPA068838 Supported Approved Mitochondria Group enriched 6 gallbladder: 575.2;kidney: 1428.7;salivary gland: 383.4 pancreas: 134.6 GLYATL2 BXMAS2-10, MGC24009 ENSG00000156689 Glycine-N-acyltransferase-like 2 11 58834065-58904215 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA060292, HPA065454 Uncertain Approved Mitochondria Group enriched 6 breast: 14.1;cervix, uterine: 27.3;gallbladder: 11.0 salivary gland: 3.0 GPHA2 A2, GPA2, MGC126572, ZSIG51 ENSG00000149735 Glycoprotein hormone alpha 2 11 64934471-64935888 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 gallbladder: 26.4;pancreas: 76.9 testis: 7.9 ONECUT1 HNF-6, HNF6, HNF6A ENSG00000169856 One cut homeobox 1 15 52756989-52791078 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003457 Approved Group enriched 6 gallbladder: 8.5;liver: 5.9;pancreas: 2.3;testis: 1.8 bone marrow: 0.7 PDZK1IP1 DD96, MAP17, SPAP ENSG00000162366 PDZK1 interacting protein 1 1 47183593-47191044 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014907 Approved Approved Nuclear speckles
Cytosol Group enriched 6 gallbladder: 299.6;kidney: 1048.6 esophagus: 121.8 SLC17A4 KIAA2138 ENSG00000146039 Solute carrier family 17, member 4 6 25754699-25781191 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055564 Approved Group enriched 6 colon: 20.8;duodenum: 29.4;gallbladder: 25.5;liver: 22.4;rectum: 29.4;small intestine: 35.7 pancreas: 4.2 UGT2B15 UGT2B8 ENSG00000196620 UDP glucuronosyltransferase 2 family, polypeptide B15 4 68537413-68670628 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045108 Approved Group enriched 6 colon: 23.8;duodenum: 30.6;gallbladder: 114.5;liver: 108.6;small intestine: 33.9 stomach: 10.2 AC234582.2 ENSG00000279986 1 155188587-155189452 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Group enriched 5 esophagus: 6.9;fallopian tube: 6.0;gallbladder: 21.0;lung: 6.9;stomach: 30.2 kidney: 2.6 AKR1C2 BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD ENSG00000151632 Aldo-keto reductase family 1, member C2 10 4922564-5135226 Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB047304, HPA068265 Approved Approved Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol Group enriched 5 adipose tissue: 352.3;breast: 122.0;esophagus: 118.4;gallbladder: 189.9;liver: 186.5;stomach: 138.5;urinary bladder: 186.3 duodenum: 33.7 ANXA13 ANX13 ENSG00000104537 Annexin A13 8 123680794-123737407 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018535, HPA019569, HPA019650, CAB025135 Supported Supported Plasma membrane Group enriched 5 duodenum: 304.7;fallopian tube: 91.6;gallbladder: 228.3;small intestine: 240.9 rectum: 39.8 B3GALT5 B3GalT-V, B3T5, beta3Gal-T5, GLCT5 ENSG00000183778 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 21 39556442-39673137 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054092, HPA054684 Approved Group enriched 5 colon: 23.1;duodenum: 28.2;gallbladder: 8.6;rectum: 41.3;small intestine: 37.9 stomach: 5.1 SLC15A1 HPECT1, HPEPT1, PEPT1 ENSG00000088386 Solute carrier family 15 (oligopeptide transporter), member 1 13 98683801-98752654 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002827 Uncertain Approved Nucleoplasm
Cytosol Group enriched 5 duodenum: 157.7;gallbladder: 68.0;small intestine: 230.1 skin: 27.9 SYT8 DKFZp434K0322 ENSG00000149043 Synaptotagmin VIII 11 1828307-1837521 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052700 Uncertain Approved Nucleoplasm
Cell Junctions Group enriched 5 gallbladder: 26.7;skin: 80.3;urinary bladder: 25.5 seminal vesicle: 8.5 VNN1 Tiff66 ENSG00000112299 Vanin 1 6 132681590-132714049 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064145 Approved Group enriched 5 duodenum: 176.1;gallbladder: 175.5;liver: 142.6;small intestine: 108.8 kidney: 27.4 ABHD16A BAT5, D6S82E, NG26 ENSG00000204427 Abhydrolase domain containing 16A 6 31686949-31703444 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058606 Approved Tissue enhanced 0 gallbladder: 1.7;testis: 1.3;thyroid gland: 1.3 esophagus: 0.9 ADAMTS14 ENSG00000138316 ADAM metallopeptidase with thrombospondin type 1 motif, 14 10 70672803-70762441 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA034605 Uncertain Cytosol Tissue enhanced 0 gallbladder: 10.9;placenta: 11.0 urinary bladder: 4.5 ADAMTS16 ADAMTS16s ENSG00000145536 ADAM metallopeptidase with thrombospondin type 1 motif, 16 5 5140330-5320304 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 10.0;ovary: 11.4 adipose tissue: 6.3 ADCYAP1 PACAP ENSG00000141433 Adenylate cyclase activating polypeptide 1 (pituitary) 18 904943-912172 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA065887 Approved Tissue enhanced 0 appendix: 19.7;cerebral cortex: 16.1;gallbladder: 15.7 testis: 5.7 AKR1B10 AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI ENSG00000198074 Aldo-keto reductase family 1, member B10 (aldose reductase) 7 134527592-134541408 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020280, CAB070163, HPA073633 Supported Supported Plasma membrane
Cytosol Tissue enhanced 0 duodenum: 653.4;gallbladder: 284.3;small intestine: 396.0;stomach: 417.4 esophagus: 90.2 AKR1C3 ENSG00000282883 Aldo-keto reductase family 1, member C3 10 5048812-5107503 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA068265 Approved Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol Tissue enhanced 0 duodenum: 254.5;gallbladder: 246.9 small intestine: 168.3 ARL14 ARF7, FLJ22595 ENSG00000179674 ADP-ribosylation factor-like 14 3 160677159-160678452 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 209.4;stomach: 70.4 duodenum: 52.4 B3GALT2 beta3Gal-T2 ENSG00000162630 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 1 193179045-193186654 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA078659 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 29.0;gallbladder: 26.0 heart muscle: 16.2 BDKRB1 B1BKR, BKR1, bradyb1 ENSG00000100739 Bradykinin receptor B1 14 96255824-96268967 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA002935 Approved Tissue enhanced 0 gallbladder: 18.3;urinary bladder: 10.3 appendix: 7.0 C11orf91 ENSG00000205177 Chromosome 11 open reading frame 91 11 33698261-33700801 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA047064, HPA050487 Uncertain Validated Vesicles Tissue enhanced 0 gallbladder: 7.8;testis: 6.9 adipose tissue: 5.7 C14orf105 FLJ10650 ENSG00000100557 Chromosome 14 open reading frame 105 14 57469301-57493867 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029202 Uncertain Nucleus
Cytosol Tissue enhanced 0 fallopian tube: 43.3;gallbladder: 27.2;kidney: 63.2 liver: 11.3 C6orf141 MGC46457 ENSG00000197261 Chromosome 6 open reading frame 141 6 49550646-49561907 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036199 Uncertain Approved Nuclear membrane Tissue enhanced 0 gallbladder: 9.3 duodenum: 6.4 CA9 CAIX, MN ENSG00000107159 Carbonic anhydrase IX 9 35673856-35681159 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005100, CAB017107, HPA055207 Supported Validated Plasma membrane
Cytosol Tissue enhanced 0 gallbladder: 36.1;stomach: 92.4 small intestine: 14.8 CCL20 CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38 ENSG00000115009 Chemokine (C-C motif) ligand 20 2 227813842-227817564 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 270.5;tonsil: 161.2 urinary bladder: 86.7 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supported Tissue enhanced 0 gallbladder: 89.6;rectum: 50.1 colon: 47.0 CHRM2 ENSG00000181072 Cholinergic receptor, muscarinic 2 7 136868669-137020255 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022338, HPA029795 Approved Tissue enhanced 0 gallbladder: 18.4;heart muscle: 26.7;smooth muscle: 13.6 urinary bladder: 6.1 CILP2 MGC45771 ENSG00000160161 Cartilage intermediate layer protein 2 19 19538248-19546659 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041847 Uncertain Tissue enhanced 0 gallbladder: 2.5;testis: 4.2 adipose tissue: 0.8 CLCF1 BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6 ENSG00000175505 Cardiotrophin-like cytokine factor 1 11 67364168-67374177 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042444 Uncertain Approved Nuclear bodies
Vesicles Tissue enhanced 0 gallbladder: 26.4 endometrium: 21.4 CLDN2 ENSG00000165376 Claudin 2 X 106900164-106930861 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002609, HPA051548 Supported Supported Nucleoplasm
Cell Junctions Tissue enhanced 0 gallbladder: 159.7;kidney: 170.5;seminal vesicle: 128.0 epididymis: 40.4 CNTNAP5 caspr5, FLJ31966 ENSG00000155052 Contactin associated protein-like 5 2 124025287-124915287 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA069095, HPA069356 Supported Nucleus
Nucleoli fibrillar center
Vesicles Tissue enhanced 0 cerebral cortex: 5.8;gallbladder: 1.6 adrenal gland: 0.7 COL10A1 ENSG00000123500 Collagen, type X, alpha 1 6 116118923-116158747 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 14.6 ovary: 4.9 COL3A1 EDS4A ENSG00000168542 Collagen, type III, alpha 1 2 188974320-189012746 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007583, CAB016766, CAB059993 Approved Tissue enhanced 0 cervix, uterine: 3775.6;gallbladder: 3342.8;smooth muscle: 2989.6 placenta: 2748.0 COLEC11 CL-K1, MGC3279 ENSG00000118004 Collectin sub-family member 11 2 3594832-3644644 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035241 Approved Tissue enhanced 0 gallbladder: 102.4 adrenal gland: 36.3 COMP EDM1, EPD1, MED, PSACH, THBS5 ENSG00000105664 Cartilage oligomeric matrix protein 19 18782773-18791314 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 24.6 smooth muscle: 18.0 CPA3 ENSG00000163751 Carboxypeptidase A3 (mast cell) 3 148865256-148897196 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006479, HPA008689, CAB020712 Supported Tissue enhanced 0 gallbladder: 174.4 lung: 126.7 CPXM1 CPX-1, CPX1, CPXM ENSG00000088882 Carboxypeptidase X (M14 family), member 1 20 2794069-2800637 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 130.2;gallbladder: 132.9 urinary bladder: 77.4 CRLF2 CRL2, TSLPR ENSG00000205755 Cytokine receptor-like factor 2 X 1187549-1212750 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 appendix: 2.1;gallbladder: 2.0 bone marrow: 1.0 CSMD2 KIAA1884 ENSG00000121904 CUB and Sushi multiple domains 2 1 33513999-34165842 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008622 Uncertain Tissue enhanced 0 cerebral cortex: 2.6;gallbladder: 1.8 testis: 1.0 CTHRC1 ENSG00000164932 Collagen triple helix repeat containing 1 8 103371515-103382997 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059806, HPA061896 Approved Approved Nucleoplasm Tissue enhanced 0 gallbladder: 138.2;placenta: 124.9;urinary bladder: 103.5 breast: 49.5 CXCL6 CKA-3, GCP-2, SCYB6 ENSG00000124875 Chemokine (C-X-C motif) ligand 6 4 73836497-73849064 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 50.4;spleen: 114.7 urinary bladder: 33.6 CYP4F11 ENSG00000171903 Cytochrome P450, family 4, subfamily F, polypeptide 11 19 15912367-15934867 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017265, CAB033648, HPA058960 Supported Tissue enhanced 0 gallbladder: 29.6;liver: 32.7;small intestine: 26.8 epididymis: 19.8 DEPDC1B BRCC3, XTP1 ENSG00000035499 DEP domain containing 1B 5 60596912-60700190 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038255, HPA072558 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 gallbladder: 33.1;testis: 22.4 lymph node: 10.9 DUOXA2 ENSG00000140274 Dual oxidase maturation factor 2 15 45114321-45118421 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA063548 Supported Tissue enhanced 0 gallbladder: 97.7;urinary bladder: 25.6 thyroid gland: 13.6 ERICH5 C8orf47, FLJ39553 ENSG00000177459 Glutamate-rich 5 8 98064311-98093610 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA025070, HPA025293, HPA027233 Supported Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 fallopian tube: 13.6;gallbladder: 13.8 stomach: 9.1 F2RL2 PAR3 ENSG00000164220 Coagulation factor II (thrombin) receptor-like 2 5 76615482-76623434 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 10.9 smooth muscle: 5.6 FAM150A UNQ9433 ENSG00000196711 Family with sequence similarity 150, member A 8 52534037-52565507 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027368 Uncertain Tissue enhanced 0 gallbladder: 3.5;thyroid gland: 3.7 cervix: 1.7 FAM180A HWKM1940, UNQ1940 ENSG00000189320 Family with sequence similarity 180, member A 7 135728348-135748846 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA021224 Uncertain Tissue enhanced 0 gallbladder: 25.6 ovary: 9.9 FGF5 ENSG00000138675 Fibroblast growth factor 5 4 80266599-80336680 Disease related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010313, HPA042442 Supported Nucleus
Nucleoli fibrillar center
Cytosol Tissue enhanced 0 gallbladder: 5.6 smooth muscle: 1.4 FGF7 KGF ENSG00000140285 Fibroblast growth factor 7 15 49423096-49488775 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043605 Uncertain Approved Nucleus
Nucleoli Tissue enhanced 0 gallbladder: 55.6 endometrium: 31.6 FNDC1 bA243O10.1, dJ322A24.1, FNDC2, KIAA1866 ENSG00000164694 Fibronectin type III domain containing 1 6 159169397-159272109 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA030962, HPA030963 Approved Supported Nuclear speckles Tissue enhanced 0 gallbladder: 23.0;thyroid gland: 33.8 smooth muscle: 16.3 FOSL1 fra-1 ENSG00000175592 FOS-like antigen 1 11 65892049-65900573 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004396, HPA066901 Uncertain Validated Nucleoplasm Tissue enhanced 0 adipose tissue: 35.2;gallbladder: 51.8 urinary bladder: 27.7 FOXL1 FKH6, FKHL11, FREAC7 ENSG00000176678 Forkhead box L1 16 86576368-86582160 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 gallbladder: 8.4 duodenum: 3.2 GCNT3 C2/4GnT, C2GnT-M, C2GnT2 ENSG00000140297 Glucosaminyl (N-acetyl) transferase 3, mucin type 15 59594875-59640239 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA011154 Approved Approved Golgi apparatus
Vesicles Tissue enhanced 0 colon: 144.6;gallbladder: 118.5;rectum: 136.6;small intestine: 141.0 duodenum: 100.5 GEM KIR ENSG00000164949 GTP binding protein overexpressed in skeletal muscle 8 94249253-94262350 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024798 Approved Tissue enhanced 0 gallbladder: 366.0 endometrium: 155.7 GLP2R ENSG00000065325 Glucagon-like peptide 2 receptor 17 9822206-9892102 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level CAB022690, HPA049244 Supported Supported Plasma membrane Tissue enhanced 0 gallbladder: 19.4 duodenum: 10.4 GPBAR1 BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5 ENSG00000179921 G protein-coupled bile acid receptor 1 2 218259496-218263859 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062890 Approved Tissue enhanced 0 gallbladder: 27.0;smooth muscle: 13.8 adipose tissue: 10.0 GPX2 GSHPX-GI ENSG00000176153 Glutathione peroxidase 2 14 64939152-64942905 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003545 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 gallbladder: 699.5;rectum: 466.5 stomach: 338.1 GREM1 CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS ENSG00000166923 Gremlin 1, DAN family BMP antagonist 15 32717974-32745107 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007526 Uncertain Tissue enhanced 0 gallbladder: 92.7;smooth muscle: 66.3 urinary bladder: 23.3 GREM2 CKTSF1B2, DAND3, FLJ21195, Prdc ENSG00000180875 Gremlin 2, DAN family BMP antagonist 1 240489573-240612149 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB009920 Approved Tissue enhanced 0 gallbladder: 49.0;parathyroid gland: 77.1 rectum: 22.9 HIST1H2AK H2A/d, H2AFD ENSG00000275221 Histone cluster 1, H2ak 6 27837947-27838339 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041189 Supported Tissue enhanced 0 gallbladder: 1.9 testis: 1.8 HNF1B HNF1beta, LFB3, MODY5, TCF2, VHNF1 ENSG00000275410 HNF1 homeobox B 17 37686432-37745247 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002083, CAB068192 Supported Supported Nucleoplasm Tissue enhanced 0 gallbladder: 21.6;kidney: 25.2 lung: 9.6 HS3ST1 3OST1 ENSG00000002587 Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 4 11393150-11429765 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA002237 Approved Approved Vesicles Tissue enhanced 0 gallbladder: 14.0;ovary: 23.1 urinary bladder: 5.8 IL11 AGIF, IL-11 ENSG00000095752 Interleukin 11 19 55364389-55370463 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044955 Uncertain Mitochondria Tissue enhanced 0 appendix: 5.8;endometrium: 5.2;gallbladder: 4.9 skin: 1.7 INHBA ENSG00000122641 Inhibin, beta A 7 41685114-41703108 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020031 Uncertain Tissue enhanced 0 endometrium: 28.7;gallbladder: 35.0 lung: 16.4 ITGBL1 OSCP, TIED ENSG00000198542 Integrin, beta-like 1 (with EGF-like repeat domains) 13 101452593-101720856 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA005676 Uncertain Tissue enhanced 0 gallbladder: 60.1 placenta: 46.8 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, modifier subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.3;gallbladder: 3.8;seminal vesicle: 4.2 testis: 1.7 KERA CNA2, SLRR2B ENSG00000139330 Keratocan 12 91050491-91057983 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA039321 Uncertain Tissue enhanced 0 gallbladder: 1.5 breast: 0.8 KIF12 ENSG00000136883 Kinesin family member 12 9 114086126-114099227 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA020192, HPA024127 Uncertain Approved Mitochondria Tissue enhanced 0 gallbladder: 31.6;kidney: 37.9 thyroid gland: 28.6 LCN2 24p3, NGAL ENSG00000148346 Lipocalin 2 9 128149071-128153455 Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002695, CAB016549, CAB016550 Supported Tissue enhanced 0 bone marrow: 1855.7;gallbladder: 3437.6 cervix: 1153.6 LGALS2 HL14 ENSG00000100079 Lectin, galactoside-binding, soluble, 2 22 37570246-37582616 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003536, CAB025198 Supported Approved Nucleoplasm
Mitochondria Tissue enhanced 0 gallbladder: 539.7;small intestine: 229.5 kidney: 154.8 LGALS9B ENSG00000170298 Lectin, galactoside-binding, soluble, 9B 17 20449395-20467539 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA046876, HPA047218 Approved Uncertain Cytosol Tissue enhanced 0 gallbladder: 11.7;rectum: 12.0;stomach: 29.2 colon: 7.7 LGALS9C ENSG00000171916 Lectin, galactoside-binding, soluble, 9C 17 18476737-18494945 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA046876, HPA047218 Approved Approved Cytosol Tissue enhanced 0 gallbladder: 9.9;rectum: 10.3;stomach: 19.9 colon: 5.5 LIF CDF, DIA, HILDA ENSG00000128342 Leukemia inhibitory factor 22 30240447-30246851 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA018844, CAB025985 Approved Validated Cytosol Tissue enhanced 0 gallbladder: 75.8 urinary bladder: 43.5 LMO7DN C13orf45 ENSG00000178734 LMO7 downstream neighbor 13 75871038-75883811 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052013 Uncertain Tissue enhanced 0 gallbladder: 1.4 testis: 0.7 LUM LDC, SLRR2D ENSG00000139329 Lumican 12 91102629-91111831 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 932.2 placenta: 597.0 LYPD6 MGC52057 ENSG00000187123 LY6/PLAUR domain containing 6 2 149329985-149474148 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042805 Uncertain Approved Cytosol Tissue enhanced 0 gallbladder: 17.3;placenta: 22.4 breast: 11.8 LYPD6B CT116, LYPD7 ENSG00000150556 LY6/PLAUR domain containing 6B 2 149038107-149215262 Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049239 Uncertain Tissue enhanced 0 gallbladder: 58.8;skin: 56.6 testis: 42.1 MFAP2 MAGP, MAGP-1 ENSG00000117122 Microfibrillar-associated protein 2 1 16974502-16980835 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA007354 Supported Tissue enhanced 0 gallbladder: 101.1 endometrium: 82.2 MMP1 CLG ENSG00000196611 Matrix metallopeptidase 1 11 102789920-102798160 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004920 Supported Vesicles Tissue enhanced 0 appendix: 39.7;gallbladder: 126.6 urinary bladder: 30.2 MMP19 MMP18, RASI-1 ENSG00000123342 Matrix metallopeptidase 19 12 55835433-55842966 Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070804 Approved Endoplasmic reticulum
Vesicles Tissue enhanced 0 adipose tissue: 63.1;gallbladder: 97.5 placenta: 27.9 MMP2 CLG4, CLG4A, TBE-1 ENSG00000087245 Matrix metallopeptidase 2 16 55389700-55506691 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001939, CAB002788 Approved Uncertain Vesicles
Cytosol Tissue enhanced 0 gallbladder: 1688.5 urinary bladder: 944.6 MMP7 MPSL1, PUMP-1 ENSG00000137673 Matrix metallopeptidase 7 11 102520508-102530753 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025869, HPA051358 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 gallbladder: 824.4 breast: 201.5 MPP6 p55T, PALS2, VAM-1 ENSG00000105926 Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) 7 24573268-24694193 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019085, HPA020456 Approved Tissue enhanced 0 gallbladder: 30.0;testis: 45.1 cerebral cortex: 14.9 MUC3A MUC3 ENSG00000169894 Mucin 3A, cell surface associated 7 100949555-100968346 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level HPA010871 Uncertain Tissue enhanced 0 duodenum: 42.7;gallbladder: 21.9;small intestine: 37.9 rectum: 14.7 NCMAP C1orf130, FLJ42528, MP11 ENSG00000184454 Noncompact myelin associated protein 1 24556111-24609328 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA013656 Uncertain Tissue enhanced 0 gallbladder: 11.5 thyroid gland: 7.1 OLFML2B DKFZP586L151 ENSG00000162745 Olfactomedin-like 2B 1 161983192-162023854 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA054136, HPA062739 Approved Approved Cytosol Tissue enhanced 0 gallbladder: 77.2 placenta: 58.1 ONECUT2 OC-2 ENSG00000119547 One cut homeobox 2 18 57435685-57491297 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA057058 Approved Supported Nucleoplasm
Actin filaments Tissue enhanced 0 duodenum: 10.6;gallbladder: 16.4 liver: 4.5 PLD1 ENSG00000075651 Phospholipase D1, phosphatidylcholine-specific 3 171600405-171810950 Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004527, HPA042396 Approved Approved Plasma membrane Tissue enhanced 0 gallbladder: 138.8 small intestine: 50.2 PLPP4 DPPL2, PPAPDC1, PPAPDC1A ENSG00000203805 Phospholipid phosphatase 4 10 120456954-120589855 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045188 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 17.2;gallbladder: 10.4;testis: 12.7 kidney: 7.7 PODN MGC24995, PCAN, PODOCAN, SLRR5A ENSG00000174348 Podocan 1 53062052-53085502 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 161.7 ovary: 107.3 PRDM6 ENSG00000061455 PR domain containing 6 5 123089121-123194266 Enzymes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030322, HPA030324 Uncertain Uncertain Nucleoplasm Tissue enhanced 0 gallbladder: 5.2;placenta: 5.9 lung: 4.0 RDH12 FLJ30273, LCA13, RP53, SDR7C2 ENSG00000139988 Retinol dehydrogenase 12 (all-trans/9-cis/11-cis) 14 67701886-67734452 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 27.9;skin: 58.4 kidney: 13.6 RNF183 MGC4734 ENSG00000165188 Ring finger protein 183 9 113297093-113303376 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057675 Uncertain Tissue enhanced 0 epididymis: 19.6;gallbladder: 9.0 kidney: 4.3 RP5-877J2.1 ENSG00000250424 7 30852273-30923812 Predicted membrane proteins Evidence at protein level Evidence at protein level HPA019206, HPA030130 Approved Approved Plasma membrane Tissue enhanced 0 gallbladder: 1.3 fallopian tube: 1.0 SERPINA4 KAL, kallistatin, KLST, KST, PI4 ENSG00000100665 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 14 94561091-94569913 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003607 Approved Tissue enhanced 0 gallbladder: 72.9;liver: 242.4 epididymis: 42.1 SERPINE1 PAI, PAI1, PLANH1 ENSG00000106366 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 7 101127089-101139266 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050039 Approved Approved Cytosol Tissue enhanced 0 gallbladder: 581.0;placenta: 595.2 adipose tissue: 213.2 SFRP2 FRP-2, SARP1, SDF-5 ENSG00000145423 Secreted frizzled-related protein 2 4 153780592-153789120 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 491.6;urinary bladder: 528.8 esophagus: 235.0 SLC1A7 EAAT5 ENSG00000162383 Solute carrier family 1 (glutamate transporter), member 7 1 53087179-53142632 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 8.5 fallopian tube: 4.4 SLC28A3 CNT3 ENSG00000197506 Solute carrier family 28 (concentrative nucleoside transporter), member 3 9 84275457-84340683 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA023311, HPA024729 Approved Tissue enhanced 0 breast: 10.7;gallbladder: 11.7;skin: 9.8 bone marrow: 6.2 SLC38A11 AVT2, FLJ39822 ENSG00000169507 Solute carrier family 38, member 11 2 164896186-164955525 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043432 Uncertain Tissue enhanced 0 epididymis: 47.1;gallbladder: 28.3 seminal vesicle: 23.3 SNAI1 SLUGH2, SNA, SNAH, SNAIL, SNAIL1 ENSG00000124216 Snail family zinc finger 1 20 49982999-49988886 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB005883 Supported Supported Nucleus
Cytosol Tissue enhanced 0 gallbladder: 26.3 thyroid gland: 13.3 SPON1 f-spondin, KIAA0762 ENSG00000262655 Spondin 1, extracellular matrix protein 11 13962689-14267884 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 gallbladder: 168.2 fallopian tube: 103.7 SPP1 BNSP, BSPI, ETA-1, OPN ENSG00000118785 Secreted phosphoprotein 1 4 87975650-87983426 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002212, HPA027540, HPA027541 Approved Supported Golgi apparatus Tissue enhanced 0 gallbladder: 4002.0;kidney: 2385.1;placenta: 4016.3 cerebral cortex: 797.1 SULT1C4 SULT1C, SULT1C2 ENSG00000198075 Sulfotransferase family, cytosolic, 1C, member 4 2 108377911-108388057 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034530 Approved Cytosol Tissue enhanced 0 gallbladder: 41.6 ovary: 31.1 SYT13 KIAA1427 ENSG00000019505 Synaptotagmin XIII 11 45240301-45286319 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046224, HPA056602 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 70.1;gallbladder: 33.0 small intestine: 14.7 TBC1D3E ENSG00000278599 TBC1 domain family, member 3E 17 38005561-38138862 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA046969, HPA047745, HPA052553 Uncertain Uncertain Vesicles Tissue enhanced 0 bone marrow: 1.8;gallbladder: 2.7;testis: 3.8 lymph node: 0.9 TCN1 TC1, TCI ENSG00000134827 Transcobalamin I (vitamin B12 binding protein, R binder family) 11 59852800-59866575 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 bone marrow: 124.0;gallbladder: 256.1;salivary gland: 317.5 stomach: 76.1 THBS2 TSP2 ENSG00000186340 Thrombospondin 2 6 169215780-169254044 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017716, HPA044304 Approved Approved Nuclear speckles
Plasma membrane
Cytosol Tissue enhanced 0 gallbladder: 113.8 endometrium: 71.0 TNFAIP6 TSG-6, TSG6 ENSG00000123610 Tumor necrosis factor, alpha-induced protein 6 2 151357592-151380048 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032719, HPA050884 Approved Tissue enhanced 0 appendix: 39.5;gallbladder: 31.9 urinary bladder: 18.9 TNFSF18 AITRL, hGITRL, TL6 ENSG00000120337 Tumor necrosis factor (ligand) superfamily, member 18 1 173039960-173050963 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012699 Uncertain Tissue enhanced 0 cerebral cortex: 2.9;gallbladder: 3.1 parathyroid gland: 1.4 TPSAB1 TPS1, TPS2, TPSB1 ENSG00000172236 Tryptase alpha/beta 1 16 1240696-1242554 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB016369, CAB022175, HPA049153, HPA049554 Supported Tissue enhanced 0 gallbladder: 212.7 lung: 158.8 TPSB2 ENSG00000197253 Tryptase beta 2 (gene/pseudogene) 16 1227272-1230184 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA049153, HPA049554 Supported Tissue enhanced 0 gallbladder: 157.9 lung: 117.7 TSLP ENSG00000145777 Thymic stromal lymphopoietin 5 111070062-111078024 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 15.1 prostate: 10.1 UGT1A8 UGT1H ENSG00000242366 UDP glucuronosyltransferase 1 family, polypeptide A8 2 233617645-233773310 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 colon: 16.2;gallbladder: 10.4;rectum: 9.8;urinary bladder: 23.5 small intestine: 5.0 UGT2A3 FLJ21934 ENSG00000135220 UDP glucuronosyltransferase 2 family, polypeptide A3 4 68928463-68951791 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045108 Supported Tissue enhanced 0 duodenum: 84.3;gallbladder: 46.5;kidney: 46.4;small intestine: 87.8 rectum: 24.3 WNT7A ENSG00000154764 Wingless-type MMTV integration site family, member 7A 3 13816258-13880121 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA015719, CAB025894 Approved Tissue enhanced 0 cerebral cortex: 6.7;gallbladder: 3.7;placenta: 3.9 lung: 3.0 ZPLD1 ENSG00000170044 Zona pellucida-like domain containing 1 3 102099244-102479841 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 gallbladder: 3.5;testis: 1.3 duodenum: 0.9